journal article·2023-11

Acidity‐Responsive Nanoreactors Destructed “Warburg Effect” for Toxic‐Acidosis and Starvation Synergistic Therapy

Jiawei Zhu, Hao Cai, Chengshuang Xu, Wenjun Wang, Xuejiao Song, Buhong Li, Yi Shen, Xiaochen Dong

Small· Volume 19· Issue 46
Publisher page

Abstract

Abstract “Warburg Effect” shows that most tumor cells rely on aerobic glycolysis for energy supply, leading to malignant energy deprivation and an “internal alkaline external acid” tumor microenvironment. Destructing the “Warburg Effect” is an effective approach to inhibit tumor progression. Herein, an acidity‐responsive nanoreactor (Au@CaP‐Flu@HA) is fabricated for toxic acidosis and starvation synergistic therapy. In the nanoreactor, the fluvastatin (Flu) could reduce lactate efflux by inhibiting the lactate‐proton transporter (monocarboxylate transporters, MCT4), resulting in intracellular lactate accumulation. Meanwhile, the glucose oxidase‐mimic Au‐nanocomposite consumes glucose to induce cell starvation accompanied by gluconic acid production, coupling with lactate to exacerbate toxic acidosis. Also, the up‐regulated autophagic energy supply of tumor cells under energy deprivation and hypoxia aggravation is blocked by autophagy inhibitor CaP. Cellular dysfunction under pHi acidification and impaired Adenosine Triphosphate (ATP) synthesis under starvation synergistically promote tumor cell apoptosis. Both in vitro and in vivo studies demonstrate that this combinational approach of toxic‐acidosis/starvation therapy could effectively destruct the “Warburg Effect” to inhibit tumor growth and anti‐metastatic effects.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Nanoplatforms for cancer theranostics · ATP Synthase and ATPases Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM) School of Physical and Mathematical Sciences Nanjing Tech University (NanjingTech) Nanjing 211816 China

School of Physical Science and Information Technology Liaocheng University Liaocheng 252059 China

MOE Key Laboratory of OptoElectronic Science and Technology for Medicine Fujian Provincial Key Laboratory for Photonics Technology Fujian Normal University Fuzhou 350117 China

School of Chemistry and Materials Science Jiangsu Normal University Xuzhou 221116 China

References (34)

Show source-provided references
1. 10.1111/brv.1251310.1111/brv.12513 ↗
2. 10.1038/s42255-020-00317-z10.1038/s42255-020-00317-z ↗
3. 10.1038/s41556-019-0299-010.1038/s41556-019-0299-0 ↗
4. 10.1016/j.cmet.2018.04.02210.1016/j.cmet.2018.04.022 ↗
5. 10.1038/s42255-020-0172-210.1038/s42255-020-0172-2 ↗
6. 10.1007/s10555-019-09792-710.1007/s10555-019-09792-7 ↗
7. 10.1038/s41573-021-00339-610.1038/s41573-021-00339-6 ↗
8. 10.1038/nn.351010.1038/nn.3510 ↗
9. 10.1016/j.ccell.2021.06.00610.1016/j.ccell.2021.06.006 ↗
10. 10.1016/j.nantod.2022.10143310.1016/j.nantod.2022.101433 ↗
11. 10.1016/j.biomaterials.2022.12146210.1016/j.biomaterials.2022.121462 ↗
12. 10.1038/s41467-022-30436-y10.1038/s41467-022-30436-y ↗
13. 10.1002/advs.20210146710.1002/advs.202101467 ↗
14. 10.1007/s10555-019-09787-410.1007/s10555-019-09787-4 ↗
15. 10.4161/auto.2790110.4161/auto.27901 ↗
16. 10.1016/j.semcancer.2019.08.02510.1016/j.semcancer.2019.08.025 ↗
17. 10.1007/s10555-019-09796-310.1007/s10555-019-09796-3 ↗
18. 10.1016/S0959-8049(11)70712-210.1016/S0959-8049(11)70712-2 ↗
19. 10.1016/j.semcancer.2022.01.00110.1016/j.semcancer.2022.01.001 ↗
20. 10.1073/pnas.202249511810.1073/pnas.2022495118 ↗
21. 10.1016/j.semcancer.2017.01.00810.1016/j.semcancer.2017.01.008 ↗
22. 10.1038/s41467-018-05261-x10.1038/s41467-018-05261-x ↗
23. Semenza G. L. · J. Clin. Invest. · 2008 · 118 · 3835
24. 10.1021/acsami.1c1158310.1021/acsami.1c11583 ↗
25. 10.1038/s41586-020-03045-210.1038/s41586-020-03045-2 ↗
26. 10.1158/0008-5472.CAN-17-076410.1158/0008-5472.CAN-17-0764 ↗
27. 10.1124/pr.119.01876210.1124/pr.119.018762 ↗
28. 10.1002/advs.20210146710.1002/advs.202101467 ↗
29. 10.1038/s41568-021-00344-210.1038/s41568-021-00344-2 ↗
30. 10.1038/s43018-021-00214-810.1038/s43018-021-00214-8 ↗
31. 10.1021/acscentsci.8b0082210.1021/acscentsci.8b00822 ↗
32. 10.1016/j.nantod.2022.10137410.1016/j.nantod.2022.101374 ↗
33. 10.1002/advs.20190284710.1002/advs.201902847 ↗
34. 10.1002/anie.20181087810.1002/anie.201810878 ↗